V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300008005 | 300004345 | 1.65 | null | Curative (C) | 2015-11-24 | 2016-02-02 | Cetuximab 7 day (>Cycle 2) | N | Y | 300015534 | CISPLATIN + FLUOROURACIL |
| 300008006 | 300004359 | 1.63 | 84.6 | Palliative (P) | 2017-11-02 | 2018-07-23 | Capecitabine | 02 | N | 300015592 | CAPECITABINE + OXALIPLATIN |
| 300008007 | 300004367 | null | 68.6 | Curative (C) | 2015-12-09 | 2015-12-09 | Cisplatin + Fluorouracil + RT 5day | N | Y | 300015642 | CETUXIMAB |
| 300008009 | 300004374 | 1.84 | 109.25 | Palliative (P) | null | 2018-04-09 | Carboplatin AUC 2 - 5 | N | N | 300015714 | PACLITAXEL |
| 300008010 | 300004377 | 1.57 | 58.9 | Palliative (P) | 2015-01-20 | 2015-04-10 | Fluorouracil + Folinic Acid (Mayo) | N | null | 300015731 | OXALIPLATIN + MDG |
| 300008011 | 300004387 | 1.82 | 112 | Curative (C) | 2016-12-02 | 2016-12-03 | GEMCITABINE + NAB PACLITAXEL | 02 | null | 300015821 | TRIAL |
| 300008012 | 300004392 | 1.67 | 60.6 | null | null | 2018-07-01 | GEMCITABINE + NAB PACLITAXEL | N | N | 300015838 | CARBOPLATIN + RT |
| 300008013 | 300004394 | null | 62.2 | Palliative (P) | 2016-05-24 | 2016-05-24 | Capecitabine | null | null | 300015852 | CAPECITABINE + CISPLATIN |
| 300008014 | 300004401 | 1.62 | 63.1 | Palliative (P) | 2018-07-01 | 2018-08-11 | Gemcitabine + Capecitabine | 02 | N | 300015891 | OXALIPLATIN + MDG |
| 300008015 | 300004407 | 1.85 | null | null | 2017-06-10 | 2017-07-22 | MITOMYCIN | null | null | 300015921 | DOCETAXEL |
| 300008016 | 300006834 | 1.56 | 90 | Curative (C) | 2017-05-31 | 2017-05-31 | Cetuximab 7 day (>Cycle 2) | 02 | Y | 300015931 | CETUXIMAB |
| 300008017 | 300004413 | 1.65 | 98.2 | Palliative (P) | 2014-01-14 | 2014-07-17 | Capecitabine | N | N | 300015937 | CETUXIMAB |
| 300008018 | 300004429 | 1.7 | null | Palliative (P) | 2016-08-19 | 2016-08-12 | Carboplatin + Paclitaxel (3 weekly) | N | N | 300015996 | CISPLATIN + FLUOROURACIL |
| 300008020 | 300004452 | null | 55.2 | Palliative (P) | 2017-08-30 | 2017-12-20 | Carboplatin + Paclitaxel (3 weekly) | N | null | 300016167 | CARBOPLATIN + VINORELBINE |
| 300008021 | 300004458 | 1.7 | null | Palliative (P) | 2015-04-02 | 2015-09-03 | Trial Unspecified | 02 | null | 300016176 | CARBOPLATIN + ETOPOSIDE |
| 300008022 | 300004461 | 1.63 | 107.5 | Palliative (P) | null | 2018-01-26 | CAPECITABINE + OXALIPLATIN | N | N | 300016180 | CARBOPLATIN + ETOPOSIDE |
| 300008023 | 300004464 | 1.55 | 66.05 | Palliative (P) | 2017-10-15 | 2017-10-30 | PACLITAXEL | Y | N | 300016184 | CAPECITABINE + OXALIPLATIN |
| 300008024 | 300006847 | null | 59.5 | Palliative (P) | null | 2019-04-19 | CISPLATIN + FLUOROURACIL | 02 | N | 300016208 | CETUXIMAB |
| 300008025 | 300006848 | 1.66 | 107 | Neo-adjuvant (N) | 2013-06-17 | 2013-07-07 | Cetuximab + Radiotherapy Maint | 02 | Y | 300016214 | CETUXIMAB |
| 300008026 | 300006849 | 1.66 | 48.8 | Palliative (P) | 2014-02-08 | 2014-02-14 | CAPECITABINE + OXALIPLATIN | 02 | N | 300016220 | CETUXIMAB |
| 300008027 | 300004472 | 1.6 | 54 | Palliative (P) | 2017-10-30 | 2018-06-25 | GEMCITABINE + NAB PACLITAXEL | 02 | null | 300016224 | CETUXIMAB + RT |
| 300008028 | 300004476 | null | null | Palliative (P) | 2016-12-19 | 2016-12-20 | Carboplatin + Pemetrexed | 02 | N | 300016265 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300008030 | 300004482 | 1.79 | 81.45 | Palliative (P) | null | 2017-08-06 | GemCarbo Days 1+8 | Y | N | 300016288 | DAIICHI TRIAL |
| 300008031 | 300006861 | null | null | Palliative (P) | 2016-05-19 | 2016-07-14 | Capecitabine + Oxaliplatin 21day | N | N | 300016341 | TRIAL |
| 300008032 | 300004491 | 1.59 | null | Palliative (P) | 2009-04-19 | 2014-11-15 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300016352 | FCR |
| 300008033 | 300004496 | 0 | 44.6 | Palliative (P) | null | 2018-01-14 | Carboplatin AUC 6 - 10 | 02 | N | 300016364 | CAPECITABINE + GEMCITABINE |
| 300008034 | 300004500 | 1.7 | null | Palliative (P) | 2013-12-24 | 2014-01-22 | Carboplatin AUC 6 - 10 | N | N | 300016391 | TOPOTECAN |
| 300008035 | 300004505 | 1.55 | 68.9 | Palliative (P) | 2016-03-19 | 2017-10-07 | Cisplatin | 02 | Y | 300016413 | CAPECITABINE + RT |
| 300008036 | 300004512 | 1.59 | 52.7 | Palliative (P) | 2014-01-14 | 2014-02-04 | Carboplatin AUC 6 - 10 | N | Y | 300016451 | FLUOROURACIL |
| 300008037 | 300004544 | null | 57 | Palliative (P) | null | 2013-12-11 | Capecitabine | N | null | 300016624 | CETUXIMAB |
| 300008038 | 300004550 | 1.62 | 57.8 | Neo-adjuvant (N) | 2017-11-22 | 2017-12-05 | Cetuximab 7 day (>Cycle 2) | N | Y | 300016636 | CETUXIMAB |
| 300008039 | 300004552 | 1.59 | 91.5 | Curative (C) | 2014-09-04 | 2014-09-04 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | null | 300016644 | ESPAC TRIAL |
| 300008040 | 300004560 | 1.87 | 46.3 | Palliative (P) | 2017-08-22 | 2017-11-09 | CAPECITABINE + OXALIPLATIN | 1 | N | 300016735 | CAPECITABINE + OXALIPLATIN |
| 300008041 | 300004565 | 1.61 | 65.7 | Palliative (P) | 2014-05-22 | 2014-06-18 | Trial Unspecified | N | N | 300016740 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300008042 | 300004572 | 1.68 | 88.6 | Palliative (P) | 2015-03-21 | 2015-05-13 | Bortezomib +/- Dexamethasone | 01 | N | 300016769 | TRASTUZUMAB |
| 300008044 | 300006897 | 1.53 | 56.6 | Curative (C) | 2016-05-22 | 2016-12-17 | CAPECITABINE + OXALIPLATIN | 02 | null | 300016805 | PACLITAXEL |
| 300008045 | 300004581 | 1.56 | null | Not known (9) | 2016-10-07 | 2016-10-07 | Folfirinox | null | null | 300016814 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300008046 | 300004586 | 1.66 | 60.5 | Palliative (P) | null | 2014-10-05 | Capecitabine | N | N | 300016838 | GEMCITABINE + NAB-PACLITAXEL |
| 300008048 | 300007763 | 1.57 | 70.8 | Palliative (P) | null | 2016-04-10 | Capecitabine | 02 | N | 300016941 | CARBOPLATIN |
| 300008049 | 300004606 | 1.78 | 93.4 | Adjuvant (A) | 2015-07-02 | 2015-08-13 | KESTREL Trial | 02 | null | 300016978 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300008050 | 300004616 | 1.92 | 60 | Palliative (P) | 2015-07-31 | 2017-05-19 | Cetuximab 7 day (Cycle 1) | Y | N | 300017026 | PACLITAXEL |
| 300008051 | 300004627 | null | 63.6 | Curative (C) | 2018-06-16 | 2019-05-10 | Oxaliplatin + Modified de Gramont | 02 | null | 300017081 | CARBOPLATIN + DOCETAXEL |
| 300008052 | 300004628 | null | 74 | Disease modification (D) | 2017-07-06 | 2017-08-17 | Irinotecan + Modified De Gramont | N | N | 300017093 | NIVOLUMAB |
| 300008053 | 300004634 | 1.52 | 90 | Curative (C) | null | 2014-02-23 | Carboplatin AUC 2 - 5 | N | Y | 300017103 | CETUXIMAB + RT |
| 300008054 | 300004637 | 1.53 | null | Adjuvant (A) | 2017-07-28 | 2017-07-28 | Cetuximab + Radiotherapy Maint | N | Y | 300017106 | CARBOPLATIN + RT |
| 300008055 | 300004641 | 1.67 | 72.4 | Palliative (P) | 2015-11-05 | 2015-11-05 | Irinotecan + Modified De Gramont | N | N | 300017110 | ETOPOSIDE |
| 300008056 | 300004646 | 1.67 | 91 | Curative (C) | 2014-08-06 | 2014-08-23 | CAPECITABINE + RT | N | Y | 300017149 | CETUXIMAB + RT |
| 300008057 | 300004648 | 1.51 | 76.6 | Curative (C) | 2017-03-04 | 2017-03-05 | CETUXIMAB + RT | N | Y | 300017151 | CARBOPLATIN + RT |
| 300008058 | 300004653 | 1.63 | 89.9 | Palliative (P) | 2016-04-30 | 2016-04-30 | Cisplatin | 2 | Y | 300017221 | CISPLATIN + FLUOROURACIL |
| 300008059 | 300006932 | 1.68 | 57.6 | Palliative (P) | 2017-06-25 | 2017-07-10 | FLUOROURACIL + OXALIPLATIN | 2 | N | 300017287 | CAPECITABINE |